Warby Parker Inc.
WRBYHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, Warby Parker Inc. (WRBY) is listed under Medical Instruments & Supplies. With a market capitalization of $3.24B, it sits in mid-cap territory. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses.
Market Cap
$3.24B
Beta
1.92
P/E (TTM)
2641.00
P/E (Fwd)
39.86
EPS (TTM)
$0.01
EPS (Fwd)
$0.66
ROE
0.4%
ROA
-0.5%
Cash
$288.2M
Total Debt
$237.6M
Free CF
$32.3M
52W Change
10.4%
Annual Financials
Cash vs Debt
Warby Parker Inc. holds $288.2M in cash against $237.6M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company generates $32.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 0.4% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $598.1M (2022) to $871.9M (2025), reflecting a 46% increase over the period.
With a beta above 1.5, WRBY tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Warby Parker Inc. and its sector.